Led by Legend Capital, Macrolux Completes Nearly CNY100 million Series A Round Legend Capital Feb 16, 2023 17:09 HKT/SGT Read More
疫苗开发不断变化的全球格局:Novotech 和 Endpoints News 网络研讨会 Novotech Health Holdings Pte Ltd Feb 16, 2023 08:00 HKT/SGT Read More
백신 개발 발전의 글로벌 환경: 노보텍 및 엔드포인트 뉴스 웨비나 Novotech Health Holdings Pte Ltd Feb 16, 2023 08:00 HKT/SGT Read More
疫苗開發不斷變化的全球格局:Novotech 和 Endpoints News 網絡研討會 Novotech Health Holdings Pte Ltd Feb 16, 2023 08:00 HKT/SGT Read More
Innovation is the Key Benchmark, Focus on Four Healthcare Industry Sub-Sectors in 2023, Says Jafar Wang of Legend Capital Legend Capital Feb 15, 2023 18:58 HKT/SGT Read More
The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar Novotech Health Holdings Pte Ltd Feb 15, 2023 09:00 HKT/SGT Read More
ONERHT Foundation together with Chui Huay Lim Club and Ee Hoe Hean Club raise close to S$500,000 to promote medical care and support for disadvantaged groups ONERHT Foundation Feb 14, 2023 18:00 JST Read More
ONERHT Foundation together with Chui Huay Lim Club and Ee Hoe Hean Club raise close to S$500,000 to promote medical care and support for disadvantaged groups ONERHT Foundation Feb 14, 2023 17:00 HKT/SGT Read More
Ocumension Therapeutics Issues Positive Profit Alert for 2022 Annual Results Ocumension Therapeutics Feb 14, 2023 10:57 HKT/SGT Read More
EC Healthcare Announced Strategic Alliance with Prudential EC Healthcare Feb 13, 2023 19:09 HKT/SGT Read More
노보텍 글로벌 보고서: 아시아 태평양 지역에서 1단계 임상시험의 확고한 성장 Novotech Health Holdings Pte Ltd Feb 13, 2023 06:00 HKT/SGT Read More
First Patient in the US Dosed in a Global Multicentre Phase 3 Clinical Study of Bevacizumab for treatment of Ophthalmic Diseases Essex Bio-Technology Limited Feb 10, 2023 21:06 HKT/SGT Read More
亿胜生物宣布贝伐珠单抗眼科适应症国际多中心III期临床研究完成美国首例患者给药 Essex Bio-Technology Limited Feb 10, 2023 20:39 HKT/SGT Read More
億勝生物宣佈貝伐珠單抗眼科適應症國際多中心III期臨床研究完成美國首例患者給藥 Essex Bio-Technology Limited Feb 10, 2023 20:38 HKT/SGT Read More